101 related articles for article (PubMed ID: 8514458)
1. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells.
Azuma M; Tamatani T; Fukui K; Yoshida H; Kamogashira T; Ogino K; Suzuki T; Sato M
Int J Cancer; 1993 Jun; 54(4):669-76. PubMed ID: 8514458
[TBL] [Abstract][Full Text] [Related]
2. Effects of media conditioned by a non-metastasizing human salivary gland adenocarcinoma cell clone and metastasizing clones from salivary gland and various other tissues on the proliferation, migration and protease production of bovine aortic endothelial cells in vitro.
Azuma M; Tamatani T; Fukui K; Yoshida H; Kamogashira T; Ogino K; Nishino N; Suzuki T; Sato M
Cancer Lett; 1993 Sep; 73(2-3):85-93. PubMed ID: 8221634
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones.
Azuma M; Yuki T; Motegi K; Sato M
Int J Cancer; 1997 May; 71(5):891-6. PubMed ID: 9180161
[TBL] [Abstract][Full Text] [Related]
4. Identification of EGF as an angiogenic factor present in conditioned medium from human salivary gland adenocarcinoma cell clones with varying degrees of metastatic potential.
Azuma M; Tamatani T; Fukui K; Yuki T; Yoshida H; Bando T; Hoque MO; Kamogashira T; Ogino K; Nishino N
Cancer Lett; 1994 Sep; 84(2):189-98. PubMed ID: 8076376
[TBL] [Abstract][Full Text] [Related]
5. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
6. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones.
Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M
Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653
[TBL] [Abstract][Full Text] [Related]
7. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines.
Korczak B; Kerbel RS; Dennis J
Int J Cancer; 1991 Jun; 48(4):557-61. PubMed ID: 2045200
[TBL] [Abstract][Full Text] [Related]
9. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol.
Stearns ME; Wang M
Oncol Res; 1994; 6(4-5):195-201. PubMed ID: 7841542
[TBL] [Abstract][Full Text] [Related]
10. Decrease in gamma-actin expression, disruption of actin microfilaments and alterations in cell adhesion systems associated with acquisition of metastatic capacity in human salivary gland adenocarcinoma cell clones.
Suzuki H; Nagata H; Shimada Y; Konno A
Int J Oncol; 1998 May; 12(5):1079-84. PubMed ID: 9538132
[TBL] [Abstract][Full Text] [Related]
11. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Korczak B; Kerbel RS; Dennis JW
Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
[TBL] [Abstract][Full Text] [Related]
12. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea.
Azuma M; Momose H; Oyasu R
Cancer Res; 1990 Nov; 50(21):7062-7. PubMed ID: 2208174
[TBL] [Abstract][Full Text] [Related]
13. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
14. Morphogenesis of normal human salivary gland cells in vitro.
Azuma M; Sato M
Histol Histopathol; 1994 Oct; 9(4):781-90. PubMed ID: 7894150
[TBL] [Abstract][Full Text] [Related]
15. Enhanced proteolytic activity is responsible for the aberrant morphogenetic development of SV40-immortalized normal human salivary gland cells grown on basement membrane components.
Azuma M; Tamatani T; Fukui K; Bando T; Sato M
Lab Invest; 1994 Feb; 70(2):217-27. PubMed ID: 8139263
[TBL] [Abstract][Full Text] [Related]
16. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.
Göõz M; Göõz P; Smolka AJ
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695
[TBL] [Abstract][Full Text] [Related]
17. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
Testa JE
Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
[TBL] [Abstract][Full Text] [Related]
18. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
Tsuboi R; Rifkin DB
Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
[TBL] [Abstract][Full Text] [Related]
19. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
20. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
